Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: jimmy who wrote (5033)	5/17/1999 7:08:00 AM
From: Richard Nisbet	Read Replies (1) \| Respond to of 108040

Kim, Some info about FSON....could move some today FSON 6 1/2 positive mention by Abelson in Barron's "Undeservedly neglected stock Fusion Medical Technology with a market value of less than $60 million, nine million shares out and a decent balance sheet, has only one product - a terrific one: Floseal, a combination of collagen and thrombin, that stops active bleeding during surgery. Approved in Europe, it's a lock to gain the FDA's okay sometime this year." "Floseal is far and away superior to anything in current use, and with the potential market gauged at around $600 million, it's a healthy sum spread over only nine million shares." This stock should have a good day on Monday.....